Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

Dry eye disease (DED) is a frequently observed eye complaint, which has recently attracted
considerable research interest. Conventional therapy for DED involves the use of artificial …

Mucoadhesion is an extremely important field of adhesion science and the comprehensive
understanding and modulation of mucoadhesion can lead to lifesaving materials and …

Ocular drug delivery is a challenging field due to the unique anatomical and physiological
barriers of the eye. Biodegradable polymers have emerged as promising tools for efficient …

Commercially available ocular drug delivery systems are effective but less efficacious to
manage diseases/disorders of the anterior segment of the eye. Recent advances in …

The low bioavailability and side effects of conventional drugs for eye disease necessitate the
development of efficient drug delivery systems. Accompanying the developments of …

Ocular diseases may be treated via different routes of administration, such as topical,
intracameral, intravitreal, oral and parenteral. Among them the topical route is most accepted …

Dry eye disease (DED) is one of the most common ocular surface disorders characterised by
a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature …

Dry eye disease (DED) is a common and frequent ocular surface disease worldwide, which
can cause severe ocular surface discomfort and blurred vision. Inflammation and reactive …

Application of pharmaceutical nanotechnology (nanomedicines) for plant actives and
extracts, is gaining a tremendous growth and interest among the scientists. This emerging …